[Remote] Supervisor, Denials and Appeals at Natera

United States

Natera Logo
Not SpecifiedCompensation
N/AExperience Level
N/AJob Type
Not SpecifiedVisa
N/AIndustries

Requirements

  • Associate or bachelor’s degree in healthcare administration, Business, Finance, or related field (or equivalent years of relevant professional experience)
  • 3+ years of revenue cycle experience, including 2+ years in a supervisory or team lead role overseeing a large team
  • Knowledge of medical billing, coding (ICD-10, CPT, HCPCS), payer reimbursement policies, and healthcare compliance
  • Proficient with revenue cycle systems (e.g., Epic, Cerner, Athenahealth, or similar EHRs)
  • Strong analytical, problem-solving, and organizational skills
  • Excellent communication and interpersonal abilities
  • Ability to manage multiple tasks and meet deadlines in a fast-paced environment

Responsibilities

  • Lead and coach the Denials and Appeals team, ensuring productivity, accuracy, and compliance with payer requirements
  • Handle escalations of complex denied claims, gather payor intel, identify root causes, and utilize data to develop strategies to prevent recurring issues
  • Oversee the preparation and submission of well-documented appeals to maximize overturn success rates
  • Monitor payer trends and collaborate with internal teams to improve claim accuracy and billing processes
  • Track and report key performance metrics, including denial rates, appeal success rates, and turnaround times
  • Foster a culture of accountability, teamwork, and continuous improvement within the department
  • Ensure compliance with HIPAA, PHI, and all relevant billing and regulatory standards

Skills

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI